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Abstract 
BACKGROUND:  
Dioxins are persistent organic pollutants present in the environment. They exert their biological 
effects by binding to an intracellular receptor, the aryl hydrocarbon receptor (AhR). Activation of 
AhR leads to the induction of cytochrome p450 1A1 (CYP1A1). Expression of CYP1A1 in human 
skin is a key marker for AhR activation, and it may induce comedogenesis resulting in acne-like 
lesions known as chloracne/metabolising acquired dioxin-induced skin hamartomas (MADISH). 
The contribution of this pathway in patients seen in a busy acne clinic is unknown. 
MATERIALS AND METHODS:  
We explored the expression of CYP1A1 by immunohistochemistry in the acne lesions of 16 
patients living in the region of Naples, Italy, where epidemiological studies have suggested a 
possibly increased exposure to environmental dioxins. A composite score to outline potential 
components of the chloracne/MADISH histological pattern was used. 
RESULTS:  
CYP1A1 expression was observed in 11 lesions (69%) and was distributed in sebaceous glands, 
follicular epithelium, cystic wall and endothelial cells. The histological score for 
chloracne/MADISH was 'likely' in 3 cases and 'possible' in 11 cases. Compared to current data on 
CYP1A1 expression in the skin of 67 patients with proven exposure to AhR agonists, these data 
indicate a high incidence of AhR activation in this series. 
CONCLUSION:  
This is the first study analysing AhR activation in skin in a series of patients from a hospital-based 
acne clinic. It provides information for future controlled prospective studies. The significance of 
CYP1A1 expression in terms of AhR ligand exposure is discussed. 
 
